Please enable JavaScript to continue using this application.

Compare $NERV vs $RNA | Chartloom

Compare

$NERV vs $RNA

Minerva Neurosciences Inc · Atrium Therapeutics Inc

NERV

Minerva Neurosciences Inc

RNA

Atrium Therapeutics Inc

Compare $NERV vs $RNA

Comparing Minerva Neurosciences Inc and Atrium Therapeutics Inc

NERVMinerva Neurosciences Inc

RNAAtrium Therapeutics Inc

NERVMinerva Neurosciences Inc

Market cap

$148M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-18.9%

52W performance

12.4%

FCF yield

-17.7%

RNAAtrium Therapeutics Inc

Market cap

$144M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

22.0%

YTD performance

-88.3%

52W performance

-82.6%

FCF yield

-55.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

NERV

RNA

Detailed metrics comparison

NERV

Minerva Neurosciences Inc

RNA

Atrium Therapeutics Inc

Market Cap

NERV$148M

RNA$144M

Enterprise Value

NERV$184M

RNA$71M

Price

NERV$3.18

RNA$8.40

P/E Ratio

NERVN/A

RNAN/A

P/S Ratio

NERV0.00x

RNA3.48x

EV/Sales

NERV0.00x

RNA1.73x

EV/EBITDA

NERV28.95x

RNA0.00x

P/B Ratio

NERV19.58x

RNA0.63x

P/FCF Ratio

NERVN/A

RNAN/A

EV/FCF

NERV-7.01x

RNA-0.89x

PEG Ratio

NERVN/A

RNAN/A

Forward P/E (NTM)

NERVN/A

RNAN/A

Forward P/S (NTM)

NERVN/A

RNAN/A

Revenue (TTM)

NERV$0

RNA$41M

Revenue Growth (YoY)

NERVN/A

RNA22.0%

Forward Rev Growth

NERV534.2%

RNA-94.2%

Gross Margin (TTM)

NERV0.0%

RNA0.0%

Operating Margin (TTM)

NERV0.0%

RNA0.0%

EBITDA Margin (TTM)

NERV0.0%

RNA-215.0%

Net Margin (TTM)

NERV0.0%

RNA-209.2%

FCF Margin (TTM)

NERVN/A

RNA-193.4%

Net Income (TTM)

NERV$-395M

RNA$-86M

FCF (TTM)

NERV$-26M

RNA$-80M

EPS (TTM)

NERV-$5.00

RNA-$5.05

ROE (TTM)

NERV-16962.0%

RNA-4030.0%

ROA (TTM)

NERV-50048.0%

RNA-5864.0%

ROIC (TTM)

NERV-16962.0%

RNA-4433.7%

Cash

NERV$25M

RNA$72M

Debt

NERV$60M

RNA$0

Net Cash/Debt

NERV$-35M

RNA$72M

Current Ratio (TTM)

NERV20.14x

RNA8.73x

Quick Ratio (TTM)

NERV19.04x

RNA8.59x

Debt/Equity (TTM)

NERV0.00x

RNA0.00x

Debt/Assets (TTM)

NERV0.0%

RNA0.0%

Interest Coverage (TTM)

NERVN/A

RNAN/A

Net Debt/EBITDA (TTM)

NERV0.00x

RNA0.00x

Beta

NERV0.04

RNA1.20

52W Performance

NERV12.4%

RNA-82.6%

YTD Performance

NERV-18.9%

RNA-88.3%

% from 52W High

NERV-74.5%

RNA-88.5%

% from 52W Low

NERV42.1%

RNA10.1%

Asset Turnover (TTM)

NERV0.00x

RNA0.28x

FCF Yield (TTM)

NERV-17.7%

RNA-55.5%

Earnings Yield (TTM)

NERV-266.7%

RNA-60.1%

Dividend Yield (TTM)

NERVN/A

RNAN/A

Rule of 40

NERV0.0

RNA-171.3

EV/GP/RG

NERVN/A

RNAN/A

Ticker research

View NERV research View RNA research

Metric	NERV Minerva Neurosciences Inc	RNA Atrium Therapeutics Inc
Market & Valuation
Market Cap	$148M	$144M
Enterprise Value	$184M	$71M
Price	$3.18	$8.40
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	3.48x
EV/Sales	0.00x	1.73x
EV/EBITDA	28.95x	0.00x
P/B Ratio	19.58x	0.63x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.01x	-0.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$41M
Revenue Growth (YoY)	N/A	22.0%
Forward Rev Growth	534.2%	-94.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-215.0%
Net Margin (TTM)	0.0%	-209.2%
FCF Margin (TTM)	N/A	-193.4%
Net Income (TTM)	$-395M	$-86M
FCF (TTM)	$-26M	$-80M
EPS (TTM)	-$5.00	-$5.05
ROE (TTM)	-16962.0%	-4030.0%
ROA (TTM)	-50048.0%	-5864.0%
ROIC (TTM)	-16962.0%	-4433.7%
Financial Health
Cash	$25M	$72M
Debt	$60M	$0
Net Cash/Debt	$-35M	$72M
Current Ratio (TTM)	20.14x	8.73x
Quick Ratio (TTM)	19.04x	8.59x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.04	1.20
52W Performance	12.4%	-82.6%
YTD Performance	-18.9%	-88.3%
% from 52W High	-74.5%	-88.5%
% from 52W Low	42.1%	10.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.28x
FCF Yield (TTM)	-17.7%	-55.5%
Earnings Yield (TTM)	-266.7%	-60.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-171.3
EV/GP/RG	N/A	N/A
Ticker research	View NERV research	View RNA research

Valuation

P/S Ratio

NERV

0.00x

RNA

3.48x

EV/FCF

NERV

-7.01x

RNA

-0.89x

Growth & revenue

Revenue Growth TTM

RNA

22.0%

Forward Revenue Growth

NERV

534.2%

RNA

-94.2%

Profitability & performance

Gross Margin

NERV

0.0%

RNA

0.0%

ROE

RNA

-4030.0%

NERV

-16962.0%

FCF Yield %

NERV

-17.7%

RNA

-55.5%

52-Week Performance

NERV

12.4%

RNA

-82.6%

Detailed metrics comparison

NERV

Minerva Neurosciences Inc

RNA

Atrium Therapeutics Inc

Market Cap

NERV$148M

RNA$144M

Enterprise Value

NERV$184M

RNA$71M

Price

NERV$3.18

RNA$8.40

P/E Ratio

NERVN/A

RNAN/A

P/S Ratio

NERV0.00x

RNA3.48x

EV/Sales

NERV0.00x

RNA1.73x

EV/EBITDA

NERV28.95x

RNA0.00x

P/B Ratio

NERV19.58x

RNA0.63x

P/FCF Ratio

NERVN/A

RNAN/A

EV/FCF

NERV-7.01x

RNA-0.89x

PEG Ratio

NERVN/A

RNAN/A

Forward P/E (NTM)

NERVN/A

RNAN/A

Forward P/S (NTM)

NERVN/A

RNAN/A

Revenue (TTM)

NERV$0

RNA$41M

Revenue Growth (YoY)

NERVN/A

RNA22.0%

Forward Rev Growth

NERV534.2%

RNA-94.2%

Gross Margin (TTM)

NERV0.0%

RNA0.0%

Operating Margin (TTM)

NERV0.0%

RNA0.0%

EBITDA Margin (TTM)

NERV0.0%

RNA-215.0%

Net Margin (TTM)

NERV0.0%

RNA-209.2%

FCF Margin (TTM)

NERVN/A

RNA-193.4%

Net Income (TTM)

NERV$-395M

RNA$-86M

FCF (TTM)

NERV$-26M

RNA$-80M

EPS (TTM)

NERV-$5.00

RNA-$5.05

ROE (TTM)

NERV-16962.0%

RNA-4030.0%

ROA (TTM)

NERV-50048.0%

RNA-5864.0%

ROIC (TTM)

NERV-16962.0%

RNA-4433.7%

Cash

NERV$25M

RNA$72M

Debt

NERV$60M

RNA$0

Net Cash/Debt

NERV$-35M

RNA$72M

Current Ratio (TTM)

NERV20.14x

RNA8.73x

Quick Ratio (TTM)

NERV19.04x

RNA8.59x

Debt/Equity (TTM)

NERV0.00x

RNA0.00x

Debt/Assets (TTM)

NERV0.0%

RNA0.0%

Interest Coverage (TTM)

NERVN/A

RNAN/A

Net Debt/EBITDA (TTM)

NERV0.00x

RNA0.00x

Beta

NERV0.04

RNA1.20

52W Performance

NERV12.4%

RNA-82.6%

YTD Performance

NERV-18.9%

RNA-88.3%

% from 52W High

NERV-74.5%

RNA-88.5%

% from 52W Low

NERV42.1%

RNA10.1%

Asset Turnover (TTM)

NERV0.00x

RNA0.28x

FCF Yield (TTM)

NERV-17.7%

RNA-55.5%

Earnings Yield (TTM)

NERV-266.7%

RNA-60.1%

Dividend Yield (TTM)

NERVN/A

RNAN/A

Rule of 40

NERV0.0

RNA-171.3

EV/GP/RG

NERVN/A

RNAN/A

Ticker research

View NERV research View RNA research

Metric	NERV Minerva Neurosciences Inc	RNA Atrium Therapeutics Inc
Market & Valuation
Market Cap	$148M	$144M
Enterprise Value	$184M	$71M
Price	$3.18	$8.40
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	3.48x
EV/Sales	0.00x	1.73x
EV/EBITDA	28.95x	0.00x
P/B Ratio	19.58x	0.63x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.01x	-0.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$41M
Revenue Growth (YoY)	N/A	22.0%
Forward Rev Growth	534.2%	-94.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-215.0%
Net Margin (TTM)	0.0%	-209.2%
FCF Margin (TTM)	N/A	-193.4%
Net Income (TTM)	$-395M	$-86M
FCF (TTM)	$-26M	$-80M
EPS (TTM)	-$5.00	-$5.05
ROE (TTM)	-16962.0%	-4030.0%
ROA (TTM)	-50048.0%	-5864.0%
ROIC (TTM)	-16962.0%	-4433.7%
Financial Health
Cash	$25M	$72M
Debt	$60M	$0
Net Cash/Debt	$-35M	$72M
Current Ratio (TTM)	20.14x	8.73x
Quick Ratio (TTM)	19.04x	8.59x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.04	1.20
52W Performance	12.4%	-82.6%
YTD Performance	-18.9%	-88.3%
% from 52W High	-74.5%	-88.5%
% from 52W Low	42.1%	10.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.28x
FCF Yield (TTM)	-17.7%	-55.5%
Earnings Yield (TTM)	-266.7%	-60.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-171.3
EV/GP/RG	N/A	N/A
Ticker research	View NERV research	View RNA research